Patents by Inventor Jonathan A. Leff

Jonathan A. Leff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140058775
    Abstract: A Global Supply Chain Intelligence system (“GSCI”) adapted to predict, discover and verify commodity trade flows. Creating and maintaining a dataset that tracks real and near real-time commodity flows as they happen as an input to the GSCI. The dataset used in a business intelligence process within the GSCI to arrive at an output, such as a predicted price behavior, a price alert, a risk alert, etc. A Commodity Flow Intelligence (CFI) component that collects and analyzes information with the timeliness, detail and accuracy required to track, forecast and predict supply and demand imbalances at the discrete flow level to aid market participants in making operational trading and investment decisions, for example, in connection with a financial services system or offering providing enhanced data and tools to promote market transparency.
    Type: Application
    Filed: August 26, 2012
    Publication date: February 27, 2014
    Inventors: Ole Siig, Geoffrey C. Smith, Jonathan A. Leff, Jochen Lothar Leidner, Yan Chong Yaw
  • Patent number: 5639629
    Abstract: At the initial diagnosis of sepsis (6-24 h before the development of ARDS), serum lactate dehydrogenase (LDH) activity level is increased in septic patients who subsequently develop ARDS compared to healthy patients and septic patients who do not develop ARDS. A method is disclosed for predicting the occurrence of ARDS in a septic patient from the patient's serum level of LDH activity, which method facilitates identification of subsets of patients destined to develop ARDS and allows prospective treatment of such septic patients.
    Type: Grant
    Filed: November 30, 1994
    Date of Patent: June 17, 1997
    Assignees: The Regents of the University of Colorado, The Webb-Waring Institute for Biomedical Research
    Inventors: John E. Repine, Jonathan A. Leff
  • Patent number: 5389522
    Abstract: At the initial diagnosis of sepsis (6-24 h before the development of ARDS), serum manganese superoxide dismutase (MnSOD) levels and catalase activities are increased in septic patients who subsequently developed ARDS compared to septic patients who did not develop ARDS. Increases in MnSOD and catalase may be used to predict the occurrence of ARDS in septic patients with the same sensitivity, specificity and efficiency as parallel assessments of serum lactate dehydrogenase (LDH) and Factor VIII levels. Evaluation of serum MnSOD and catalase as well as these other accessible markers facilitates identification of subsets of patients and allows prospective treatment of septic patients who are destined to develop ARDS.
    Type: Grant
    Filed: March 19, 1993
    Date of Patent: February 14, 1995
    Inventors: John E. Repine, Jonathan A. Leff